← Leaderboards
Erik Christian Andersen
Princeton University
$6,929,319
Attributed
$11,365,447
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,365,447 · 8
By mechanism
R01$9,533,399 · 3
R21$1,744,963 · 4
F32$87,085 · 1
Top collaborators
- Larry Ryan Baugh5 shared
- Matthew Rockman5 shared
- Frank Clemens Schroeder4 shared
- Albertha Johanna Walhout4 shared
- Helen M Chamberlin2 shared
- Christopher Fang-Yen2 shared
Others in their field
Top investigators on “Nematoda”
- Robert H Waterston · Washington University$37,465,600
- Paul Warren Sternberg · California Institute Of Technology$34,689,675
- Gordon J. Lithgow · Buck Institute For Age Research$23,578,719
- Albertha Johanna Walhout · Univ Of Massachusetts Med Sch Worcester$20,063,687
- Shai Shaham · Rockefeller University$19,313,693
- Daniel Edward Lee Promislow · University Of Georgia (Uga)$18,636,312
Research focus
NematodaGenesCaenorhabditis ElegansGeneticPhenotypeExperimental StudyGenomicsAffectResponseGenome EditingCrispr/Cas TechnologyRecombinantsGenotypeLaboratoriesGenome-WideChromosome MappingVariantEvolutionGenomeAllelesMapsMolecularQuantitative GeneticsResistance
Grant awards (24)
Investigating the genetics and genomics of antiparasitic drug responses in a poultry model of ascariasis$204,688
R21 · FY2025 · AI · contact PI
Discovery of Novel Benzimidazole Resistance Mechanisms$706,189
R01 · FY2024 · AI · contact PI
Investigating the genetics and genomics of antiparasitic drug responses in a poultry model of ascariasis$245,625
R21 · FY2024 · AI · contact PI
Discovery of Novel Benzimidazole Resistance Mechanisms$711,434
R01 · FY2023 · AI · contact PI
Discovery of conserved molecular mechanisms underlying population-wide variation in toxin responses$653,236
R01 · FY2023 · ES · contact PI
Genetic and genomic tools for C. briggsae research$188,447
R21 · FY2023 · OD
Discovery of novel benzimidazole resistance mechanisms$682,073
R01 · FY2022 · AI · contact PI
Discovery of conserved molecular mechanisms underlying population-wide variation in toxin responses$667,252
R01 · FY2022 · ES · contact PI
Genetic and genomic tools for C. briggsae research$242,593
R21 · FY2022 · OD
Discovery of novel benzimidazole resistance mechanisms$696,385
R01 · FY2021 · AI · contact PI
Discovery of conserved molecular mechanisms underlying population-wide variation in toxin responses$694,440
R01 · FY2021 · ES · contact PI
Discovery of novel benzimidazole resistance mechanisms$735,967
R01 · FY2020 · AI · contact PI
Large scale nutrigenetics and genomics in a tractable metazoan model$658,905
R01 · FY2020 · DK
Discovery of conserved molecular mechanisms underlying population-wide variation in toxin responses$608,603
R01 · FY2020 · ES · contact PI
Large scale nutrigenetics and genomics in a tractable metazoan model$678,780
R01 · FY2019 · DK
Discovery of conserved molecular mechanisms underlying population-wide variation in toxin responses$607,077
R01 · FY2019 · ES · contact PI
Large scale nutrigenetics and genomics in a tractable metazoan model$693,788
R01 · FY2018 · DK
High-throughput multi-modal analysis of natural variation in C. elegans healthspan$199,000
R21 · FY2018 · AG
Large scale nutrigenetics and genomics in a tractable metazoan model$739,270
R01 · FY2017 · DK
High-throughput multi-modal analysis of natural variation in C. elegans healthspan$240,414
R21 · FY2017 · AG
Discovery and validation of avermectin resistance loci in free-living and parasitic nematodes$185,869
R21 · FY2017 · AI · contact PI
Discovery and validation of avermectin resistance loci in free-living and parasitic nematodes$238,327
R21 · FY2016 · AI · contact PI
Quantitative genetic analyses of conserved C. elegans signaling pathways$39,875
F32 · FY2010 · GM · contact PI
Quantitative genetic analyses of conserved C. elegans signaling pathways$47,210
F32 · FY2009 · GM · contact PI